Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2015

Open Access 01-12-2015 | Commentary

Depletion of highly abundant proteins from human cerebrospinal fluid: a cautionary note

Authors: Ramona Günther, Eberhard Krause, Michael Schümann, Ingolf E. Blasig, Reiner F. Haseloff

Published in: Molecular Neurodegeneration | Issue 1/2015

Login to get access

Abstract

Affinity-based techniques, both for enrichment or depletion of proteins of interest, suffer from unwanted interactions between the bait or matrix material and molecules different from the original target. This effect was quantitatively studied by applying two common procedures for the depletion of albumin/gamma immunoglobulin to human cerebrospinal fluid. Proteins of the depleted and the column-bound fraction were identified by mass spectrometry, employing 18O labeling for quantitation of their abundance. To different extents, the depletion procedures caused the loss of proteins previously suggested as biomarker candidates for neurological diseases. This is an important phenomenon to consider when quantifying protein levels in biological fluids.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roche S, Tiers L, Provansal M, Seveno M, Piva MT, Jouin P, et al. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J Proteomics. 2009;72:945–51.CrossRefPubMed Roche S, Tiers L, Provansal M, Seveno M, Piva MT, Jouin P, et al. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J Proteomics. 2009;72:945–51.CrossRefPubMed
3.
go back to reference Lange S, Sylvester M, Schümann M, Freund C, Krause E. Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry: SILAC vs O-18-labeling. J Proteome Res. 2010;9:4113–22.CrossRefPubMed Lange S, Sylvester M, Schümann M, Freund C, Krause E. Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry: SILAC vs O-18-labeling. J Proteome Res. 2010;9:4113–22.CrossRefPubMed
4.
go back to reference Cooksley-Decasper S, Reiser H, Thommen DS, Biedermann B, Neidhart M, Gawinecka J, et al. Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis. PLoS One. 2012;7, e47985.PubMedCentralCrossRefPubMed Cooksley-Decasper S, Reiser H, Thommen DS, Biedermann B, Neidhart M, Gawinecka J, et al. Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis. PLoS One. 2012;7, e47985.PubMedCentralCrossRefPubMed
5.
go back to reference Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motornura K, et al. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropath Exp Neur. 2006;65:816–25.CrossRefPubMed Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motornura K, et al. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropath Exp Neur. 2006;65:816–25.CrossRefPubMed
6.
go back to reference Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics. 2011;74:371–88.CrossRefPubMed Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics. 2011;74:371–88.CrossRefPubMed
7.
go back to reference Hasselblatt M, Bohm C, Tatenhorst L, Dinh V, Newrzella D, Keyvani K, et al. Identification of novel diagnostic markers for choroid plexus tumors - a microarray-based approach. Am J Surg Pathol. 2006;30:66–74.CrossRefPubMed Hasselblatt M, Bohm C, Tatenhorst L, Dinh V, Newrzella D, Keyvani K, et al. Identification of novel diagnostic markers for choroid plexus tumors - a microarray-based approach. Am J Surg Pathol. 2006;30:66–74.CrossRefPubMed
8.
go back to reference Noben JP, Dumont D, Kwasnikowska N, Verhaert P, Somers V, Hupperts R, et al. Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry. J Proteome Res. 2006;5:1647–57.CrossRefPubMed Noben JP, Dumont D, Kwasnikowska N, Verhaert P, Somers V, Hupperts R, et al. Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry. J Proteome Res. 2006;5:1647–57.CrossRefPubMed
9.
go back to reference Yin GN, Lee HW, Cho JY, Suk K. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases. Brain Res. 2009;1265:158–70.CrossRefPubMed Yin GN, Lee HW, Cho JY, Suk K. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases. Brain Res. 2009;1265:158–70.CrossRefPubMed
10.
go back to reference Günther R, Krause E, Schümann M, Ausseil J, Heard JM, Blasig IE, et al. Removal of albumin and immunoglobulins from canine cerebrospinal fluid using depletion kits: a feasibility study. Fluids Barriers CNS. 2014;11:14.PubMedCentralCrossRefPubMed Günther R, Krause E, Schümann M, Ausseil J, Heard JM, Blasig IE, et al. Removal of albumin and immunoglobulins from canine cerebrospinal fluid using depletion kits: a feasibility study. Fluids Barriers CNS. 2014;11:14.PubMedCentralCrossRefPubMed
Metadata
Title
Depletion of highly abundant proteins from human cerebrospinal fluid: a cautionary note
Authors
Ramona Günther
Eberhard Krause
Michael Schümann
Ingolf E. Blasig
Reiner F. Haseloff
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2015
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/s13024-015-0050-7

Other articles of this Issue 1/2015

Molecular Neurodegeneration 1/2015 Go to the issue